Trastuzumab (Herceptin) as adjuvant treatment of HER-2 positive primary breast cancer

This report is a summary of recommendations by Zorginstituut Nederland. The original text is in Dutch.

Download "Trastuzumab (Herceptin) as adjuvant treatment of HER-2 positive primary breast cancer"

PDF document | 58 kB

Report | 20-12-2010